The deal structure involves creating a new entity, 'TAVR-Structural Heart NewCo', which will require significant resource allocation and potential new systems upon acquisition.
Filing excerpt
On May 18, 2026, Boston Scientific Corporation (the “Company”) issued a press release announcing that the Company has entered into an investment agreement (the “Investment Agreement”) with MiRus LLC (“MiRus”)
What this signalsIntegration work after a deal often opens needs for new systems and services.
Technologies
Regions named
sec-8kacquisitionAnnouncedGet every 8-K signal for Boston Scientific and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Boston Scientific this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/82bceeac-b61c-4baf-94f6-cf5ccf1aafbe returns this record as JSON. POST /v1/companies/enrich returns every signal for bostonscientific.com.
{
"signal_id": "82bceeac-b61c-4baf-94f6-cf5ccf1aafbe",
"signal_type": "sec-8k",
"signal_subtype": "acquisitionAnnounced",
"detected_at": "2026-05-19T10:14:18.378+00:00",
"company": {
"name": "Boston Scientific",
"domain": "bostonscientific.com"
},
"data": {
"detail": "This multi-billion dollar investment signals a major strategic push into the transcatheter aortic valve replacement (TAVR) market, creating budget and opportunities for vendors supporting M&A integration, clinical trial management, and regulatory affairs. The deal structure involves creating a new entity, 'TAVR-Structural Heart NewCo', which will require significant resource allocation and potential new systems upon acquisition.",
"metrics": {
"pct": 0.3375,
"timeframe": "immediate",
"pct_context": "Acquired 33.75% of the fully diluted equity interests of MiRus.",
"dollar_context": "$1.5B initial investment plus a $3.0B option to acquire MiRus's TAVR business.",
"dollar_millions": 4500
},
"summary": "Boston Scientific invests $1.5B with a $3B option to acquire MiRus's TAVR business.",
"excerpts": "On May 18, 2026, Boston Scientific Corporation (the “Company”) issued a press release announcing that the Company has entered into an investment agreement (the “Investment Agreement”) with MiRus LLC (“MiRus”)",
"relevance": 0.9,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/885725/000088572526000041/bsx-20260518.htm",
"filing_date": "2026-05-18",
"filing_year": 2026,
"fiscal_year_end": "05/18",
"sales_relevance": "Integration needs coming",
"signal_category": "strategic",
"regions_mentioned": [
"United States"
],
"technologies_mentioned": [
"biomaterials",
"TAVR System"
]
}
}
curl https://signals.autobound.ai/v1/signals/82bceeac-b61c-4baf-94f6-cf5ccf1aafbe \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"bostonscientific.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.